Additionally, inhibiting SDC2 expression in MDA‐MB‐231 breast cancer cells (BCCs) reduced tumour volumes and improved survival in an adoptive transfer mouse model of breast cancer.31 This evidence concerns the gene SDC2 and breast carcinoma.